Clinical Trial Update: Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of chemotherapy with dasatinib in Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression | Phase 2 | Status: COMPLETED | Results posted: 2025-02-17